These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 2145482)
1. [Allergenicity degree and sensitization percentage of minoxidil in experimental animals]. Jeremías Torruella FJ; Giménez Camarasa JM Med Cutan Ibero Lat Am; 1990; 18(2):107-11. PubMed ID: 2145482 [TBL] [Abstract][Full Text] [Related]
2. Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution. Hagemann T; Schlütter-Böhmer B; Allam JP; Bieber T; Novak N Contact Dermatitis; 2005 Jul; 53(1):53-5. PubMed ID: 15982234 [TBL] [Abstract][Full Text] [Related]
3. Pustular allergic contact dermatitis from topical minoxidil 5%. Rodríguez-Martín M; Sáez-Rodríguez M; Carnerero-Rodríguez A; Cabrera de Paz R; Sidro-Sarto M; Pérez-Robayna N; Guimerá F; Sánchez R; García-Bustínduy M; Noda-Cabrera A J Eur Acad Dermatol Venereol; 2007 May; 21(5):701-2. PubMed ID: 17447999 [No Abstract] [Full Text] [Related]
9. [Group-allergic reaction spectrum and sensitization potency of benzylisothiocyanate]. Richter G; Heidelbach U; Heidenbluth I; Kadner H Berufsdermatosen; 1976; 24(6):147-51. PubMed ID: 138417 [TBL] [Abstract][Full Text] [Related]
10. Unusual acute, nonallergic eruptions of the scalp from combined use of minoxidil and retinoic acid. Fisher AA Cutis; 1993 Jan; 51(1):17-8. PubMed ID: 8419103 [No Abstract] [Full Text] [Related]
11. [Sensitization for external treatment with minoxidil]. van Joost T Ned Tijdschr Geneeskd; 1988 Jun; 132(25):1141-2. PubMed ID: 3398938 [No Abstract] [Full Text] [Related]
12. Pruritic rash with actinic keratosis and impending exfoliation in a patient with hypertension managed with minoxidil. Ackerman BH; Townsend ME; Golden W; Bryan AB Drug Intell Clin Pharm; 1988 Sep; 22(9):702-3. PubMed ID: 2975213 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women. Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383 [TBL] [Abstract][Full Text] [Related]
14. [Predictive experimental animal test of contact allergenicity. Relevance of the methods of the OECD and EEC guidelines. The organization for Economic Co-operation and Development]. Maurer T; Hess R; Weirich EG Derm Beruf Umwelt; 1985; 33(1):6-11. PubMed ID: 3987519 [TBL] [Abstract][Full Text] [Related]
16. Experimental sensitization of guinea pigs by drugs. Comparison of the maximization test with the wholly intradermal test. Rantuccio F; Coviello C; Sinisi D; Scardigno A; Conte A Contact Dermatitis; 1983 Nov; 9(6):479-83. PubMed ID: 6653105 [TBL] [Abstract][Full Text] [Related]
17. Topical minoxidil dose-response effect in alopecia areata. Fiedler-Weiss VC; West DP; Buys CM; Rumsfield JA Arch Dermatol; 1986 Feb; 122(2):180-2. PubMed ID: 3947124 [TBL] [Abstract][Full Text] [Related]
18. The therapeutic use of topical minoxidil. DeVillez RL Dermatol Clin; 1990 Apr; 8(2):367-75. PubMed ID: 2191807 [TBL] [Abstract][Full Text] [Related]
19. Use of glycerin in topical minoxidil solutions for patients allergic to propylene glycol. Fisher AA Cutis; 1990 Feb; 45(2):81-2. PubMed ID: 2138072 [No Abstract] [Full Text] [Related]
20. Diphoterine chemical splash decontamination solution: skin sensitization study in the guinea pig. Mathieu L; Burgher F; Hall AH Cutan Ocul Toxicol; 2007; 26(3):181-7. PubMed ID: 17687683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]